Estradiol/Norethindrone/Relugolix (Myfembree) is hard to find at many pharmacies. Learn why this medication is difficult to locate and what you can do about it in 2026.
You got your prescription for Estradiol/Norethindrone/Relugolix — sold under the brand name Myfembree — and headed to the pharmacy, only to hear those frustrating words: "We don't have that in stock."
If that sounds familiar, take a deep breath. You're not alone, and this doesn't mean the medication is discontinued or permanently unavailable. There are real reasons why Estradiol/Norethindrone/Relugolix is harder to find than most prescriptions, and there are steps you can take to get it filled.
Estradiol/Norethindrone/Relugolix is a once-daily oral tablet that combines three active ingredients:
It's FDA-approved for two conditions in premenopausal women:
To learn more about how this medication works, check out our guide on how Estradiol/Norethindrone/Relugolix works.
Unlike common medications such as blood pressure pills or antibiotics, Estradiol/Norethindrone/Relugolix faces several challenges that make it harder to locate at your local pharmacy.
Myfembree is prescribed for specific conditions — uterine fibroids and endometriosis — which means it has a much smaller patient population compared to widely prescribed medications. Most retail pharmacies stock medications based on demand, and if a drug isn't frequently requested, they simply won't carry it on their shelves. This is standard practice for pharmacies trying to manage inventory costs.
With a cash price ranging from $1,300 to $1,700 per month, Myfembree is an expensive medication for pharmacies to keep on hand. Pharmacies take a financial risk when they stock high-cost specialty drugs that may sit on their shelves. If a patient doesn't pick up the prescription or insurance denies the claim, the pharmacy could be left with an expensive product it can't easily sell.
Most insurance plans require prior authorization before they'll cover Myfembree. This means your doctor needs to submit additional paperwork to your insurance company proving you need this specific medication. The prior authorization process can take days or even weeks, and during that time, a pharmacy won't order the drug until approval is confirmed. Learn more about managing costs in our guide on how to save money on Estradiol/Norethindrone/Relugolix.
As of early 2026, there is no generic version of Myfembree on the market. While some patent exclusivities have begun expiring, no generic manufacturer has received FDA approval yet. Without a generic option, the brand-name product remains the only choice, limiting supply to a single manufacturer (Myovant Sciences).
No. As of early 2026, Myfembree is not on the FDA's official drug shortage list. The difficulties patients experience are primarily related to pharmacy stocking practices and insurance barriers — not a manufacturing or supply chain problem. The medication is being produced; it's just not sitting on shelves at most pharmacies waiting for you.
The good news is that Myfembree is available — you just may need to look in the right places.
Medfinder helps you search for pharmacies that currently have Estradiol/Norethindrone/Relugolix in stock near you. Instead of calling pharmacy after pharmacy, you can check availability in one place and save yourself time and frustration.
Because Myfembree is classified as a specialty medication, it may be more readily available through specialty pharmacies that routinely handle high-cost, limited-distribution drugs. Your prescriber's office or insurance company can often direct you to a preferred specialty pharmacy.
Independent pharmacies sometimes have more flexibility in ordering specialty medications than large chain pharmacies. They may also be more willing to order Myfembree specifically for you. For more tips, see our article on how to find Estradiol/Norethindrone/Relugolix in stock near you.
If your doctor knows they'll be prescribing Myfembree, ask them to send the prescription a few days early so the pharmacy has time to order it. Most pharmacies can get it within 1–2 business days through their regular wholesale distributors.
If cost is part of the barrier, Myovant Sciences offers a Copay Assistance Program where eligible commercially insured patients may pay as little as $5 per monthly fill (up to $5,000 in annual savings). Visit myfembree.com/cost-and-support to see if you qualify.
If you've been unable to fill your Estradiol/Norethindrone/Relugolix prescription despite trying these options, talk to your doctor about whether an alternative medication might work for you. Options like Oriahnn, Orilissa, or Lupron Depot treat similar conditions, though they each have different dosing schedules and side effect profiles.
Finding Estradiol/Norethindrone/Relugolix (Myfembree) can be frustrating, but it's important to understand that the difficulty is usually about where it's stocked — not whether it exists. The medication is being manufactured and distributed. With the right approach — using tools like Medfinder, working with specialty pharmacies, and getting prior authorization squared away — most patients can successfully fill their prescriptions.
Don't give up on a medication that's working for you just because it's hard to find. There are resources available to help.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
